New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 23, 2014
06:51 EDTSCMPSucampo announces publication of NICE recommendatoin for Amitiza
Sucampo announced that the United Kingdom's National Institute of Health and Care Excellence has published the technology appraisal guidance recommending the use of AMITIZA in the treatment of chronic idiopathic constipation and associated symptoms in adults who have failed laxatives. The NICE guidance recommends AMITIZA as an option for treating CIC for adults in whom treatment with at least 2 laxatives from different classes, at the highest tolerated recommended doses for at least 6 months, has failed to provide adequate relief and for whom invasive treatment for constipation is being considered.
News For SCMP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 30, 2015
16:04 EDTSCMPSucampo appoints Andrew Smith CFO
Subscribe for More Information
06:46 EDTSCMPSucampo completes European Mutual Recognition Procedure for AMITIZA
Subscribe for More Information
January 20, 2015
10:55 EDTSCMPSucampo founders' share registration removes overhang, says Cantor
Subscribe for More Information
08:44 EDTSCMPSucampo share sales to remove big overhang, says Roth Capital
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use